Item 5. Other Information
Item 5: Other Information
Rule 10b5-1 Trading Plans
None of the Company’s directors or officers adopted , modified, or terminated a Rule 10b5-1 trading arrangement or a non-Rule
10b5-1 trading arrangement during the three months ended June 28, 2026.
Item 6: Exhibits
Exhibits
Exhibit 4.1 Second Supplemental Indenture relating to Senior Subordinated Notes due 2028
Exhibit 4.2 Second Supplemental Indenture relating to Senior Subordinated Notes due 2031
Exhibit 4.3 First Supplemental Indenture relating to Senior Subordinated Notes due 2033
Exhibit 31.1 Certificate of the Chief Executive Officer pursuant to § 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 31.2 Certificate of the Chief Financial Officer pursuant to § 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.1 Certificate of the Chief Executive Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.2 Certificate of the Chief Financial Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002.
Exhibit 101.SCH Schema Document
Exhibit 101.CAL Calculation Linkbase Document
Exhibit 101.DEF Definition Linkbase Document
Exhibit 101.LAB Labels Linkbase Document
Exhibit 101.PRE Presentation Linkbase Document
-24-
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
BELDEN INC.
Date: July 30, 2026 By: /s/ Ashish Chand
Ashish Chand
President and Chief Executive Officer
Date: July 30, 2026 By: /s/ Jeremy Parks
Jeremy Parks
Executive Vice President and Chief Financial Officer
Date: July 30, 2026 By: /s/ Douglas R. Zink
Douglas R. Zink
Vice President and Chief Accounting Officer
-25-
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.